Interaction of obesity and central obesity on elevated urinary albumin-to-creatinine ratio

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Du, Nan ^a   Peng, Hao ^a   Chao, Xiangqin ^b   Zhang, Qiu ^a,b   Tian, Honggang ^b   Li, Hongmei ^a  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b Center for Disease Prevention and Control of Jinchang District   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE; ALBUMINOID;

ADULT; ANALYTICAL PARAMETERS; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; OBESITY; OUTCOME ASSESSMENT; RISK ASSESSMENT; RISK FACTOR; SYNDROME DELINEATION; URINARY ALBUMIN TO CREATININE RATIO; WAIST HIP RATIO; ABDOMINAL OBESITY; AGED; ALBUMINURIA; COMPLICATION; CROSS-SECTIONAL STUDY; MIDDLE AGED; PATHOLOGY; RISK; URINE;

ADULT; AGED; ALBUMINS; ALBUMINURIA; BODY MASS INDEX; CREATININE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; OBESITY, ABDOMINAL; ODDS RATIO; RISK FACTORS; WAIST-HIP RATIO;

EID: 84902440685     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098926     Document Type: Article

References (31)

1. Rutkowski P, Klassen A, Sebekova K, Bahner U, Heidland A (2006). Renal disease in obesity: the need for greater attention. J Ren Nutr 16: 216-223. (Pubitemid 43975009)
2. Futrakul N, Sridama V, Futrakul P (2009). Microalbuminuria-a biomarker of renal microvascular disease. Ren Fail 31: 140-143.
3. Eckel RH, York DA, Rössner S, Hubbard V, Caterson I, et al (2004). Prevention Conference VII: Obesity, a worldwide epidemic related to heart disease and stroke: executive summary. Circulation 110: 2968-2975. (Pubitemid 39473624)
4. Chen B, Yang D, Chen Y, Xu W, Ye B, et al (2010). The prevalence of microalbuminuria and its relationships with the components of metabolic syndrome in the general population of China. Clin Chim Acta 411: 705-709.
5. Peng H, Ding J, Peng Y, Zhang Q, Xu Y, et al (2012). Hyperuricemia and Microalbuminuria Are Separately and Independently Associated with Pre-hypertension Among Chinese Han Women. Metab Syndr Relat Disord 10: 202-208.
6. Thoenes M, Reil JC, Khan BV, Bramlage P, Volpe M, et al (2009). Abdominal obesity is associated with microalbuminuria and an elevated cardiovascular risk profile in patients with hypertension. Vasc Health Risk Manag 55: 577-585.
7. Chandie Shaw PK, Berger SP, Mallat M, Frölich M, Dekker FW, et al (2007). Central obesity is an independent risk factor for albuminuria in nondiabetic south Asian subjects. Diabetes Care 30: 1840-1844. (Pubitemid 47036361)
8. Guidelines Subcommittee of the WHO/ISH Mild Hypertension Liaison Committee (1993). 1993 guidelines for the management of mild hypertension. Memorandum from a World Health Organization/International Society of Hypertension meeting. Hypertension 22: 392-403.
9. Working Group on Obesity in China, Department of Disease Control, Ministry of Health (2004). The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed Environ Sci 17: 1-35.
10. Nishida C, Ko GT, Kumanyika S (2010). Body fat distribution and noncommunicable diseases in populations: overview of the 2008 WHO Expert Consultation on Waist Circumference and Waist-Hip Ratio. Eur J Clin Nutr 64: 2-5.
11. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, et al (2013). 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8). JAMA doi: 10.1001/jama.2013.284427. [Epub ahead of print]
12. Lambers Heerspink HJ, Brantsma AH, de Zeeuw D, Bakker SJ, de Jong PE, et al (2008). Albuminuria assessed from first-morning-void urine samples versus 24-hour urine collections as a predictor of cardiovascular morbidity and mortality. Am J Epidemiol 168: 897-905.
13. K/DOQI (2002). Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39: S1-S266.
14. Hallqvist J, Ahlbom A, Diderichsen F, Reuterwall C (1996). How to evaluate interaction between causes: A review of practices in cardiovascular epidemiology. J Intern Med 239: 377-382. (Pubitemid 26246418)
15. Naidoo DP (2002). The link between microalbuminuria, endothelial dysfunction and cardiovascular disease in diabetes. Cardiovasc J S Afr 13: 194-199.
16. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, et al (2001). Albuminuria and risk of cardiovascular events, death and heart failure in diabetic and nondiabetic individuals. JAMA 286: 421-426. (Pubitemid 32681484)
17. Pedrinelli R, Dell'Omo G, Di Bello V, Pontremoli R, Mariani M (2002). Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension. J Hum Hypertens 16: 79-89. (Pubitemid 34182916)
18. Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, et al (2002). Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 106: 1777-1782.
19. Solbu MD, Kronborg J, Jenssen TG, Njølstad I, Løchen ML, et al (2009). Albuminuria, metabolic syndrome and the risk of mortality and cardiovascular events. Atherosclerosis 204: 503-508.
20. Kalmijn S, Curb JD, Rodriguez BL, Yano K, Abbott RD (1999). The association of body weight and anthropometry with mortality in elderly men: the Honolulu Heart Program. Int J Obes Relat Metab Disord 23: 395-402. (Pubitemid 29182399)
21. Baik I, Ascherio A, Rimm EB, Giovannucci E, Spiegelman D, et al (2000). Adiposity and mortality in men. Am J Epidemiol 152: 264-271. (Pubitemid 30640249)
22. Visscher TLS, Seidell JC, Molarius A, van der Kuip D, Hofman A, et al (2001). A comparison of body mass index, waist-hip ratio and waist circumference as predictors of all-cause mortality among the elderly: the Rotterdam Study. Int J Obesity Relat Metab Disord 25: 1730-1735. (Pubitemid 33052086)
23. Gray DS, Fujioka K (1991). "Use of relative weight and Body Mass Index for the determination of adiposity". J Clin Epidemiol 44: 545-50
24. Sweeting HN (2007). "Measurement and Definitions of Obesity In Childhood and Adolescence: A field guide for the uninitiated". Nutr J 6: 32.
25. WHO (2000). Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organization Technical Report Series 894: i-xii.
26. Kershaw EE, Flier JS (2004). Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89: 2548-2556. (Pubitemid 38766330)
27. Fischer-Posovszky P, Wabitsch M, Hochberg Z (2007). Endocrinology of adipose tissue- an update. Horm Metab Res 39: 314-321.
28. Agha A, Amer W, Anwar E, Bashir K (2009). Reduction of microalbuminuria by using losartan in normotensive patients with type 2 diabetes mellitus: a randomized controlled trial. Saudi J Kidney Dis Transpl 20: 429-435.
29. Palmer AJ, Roze S, Rodby RA, Valentine WJ, Ritz E, et al (2006). Clinical and health economic implications of early treatment with irbesartan of patients with type 2diabetes mellitus, hypertension and nephropathy. Dtsch Med Wochenschr 131: 1721-1726. (Pubitemid 44532020)
30. Morales E, Valero MA, León M, Hernández E, Praga M (2003). Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. Am J Kidney Dis 41: 319-327. (Pubitemid 36152449)
31. Saiki A, Nagayama D, Ohhira M, Endoh K, Ohtsuka M, et al (2005). Effect of weight loss using formula diet on renal function in obese patients with diabetic nephropathy. Int J Obesity (Lond) 29: 1115-1120. (Pubitemid 41192220)